華聯控股(000036.SZ):恆裕資本將間接成為公司實控人
格隆匯12月16日丨華聯控股(000036.SZ)公佈,2021年12月16日,公司收到深圳市恆裕資本管理有限公司(“恆裕資本”)《關於收購華僑城集團所持華聯集團股權實施進展的吿知函》,根據該函吿顯示:恆裕資本與華僑城集團有限公司(“華僑城集團”)已於2021年12月14日簽署《產權交易合同》,華僑城集團將持有的華聯集團12.08%股權轉讓給恆裕資本。此次股權轉讓後,恆裕資本與其全資子公司河南富鑫投資有限公司(“河南富鑫”)將分別持有華聯集團16.54%、53.69%股權,合計70.23%股權。恆裕資本將成為華聯集團實際控制人,並間接成為華聯控股實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.